Search

Hau Van Phan

Examiner (ID: 8779, Phone: (571)272-6696 , Office: P/3618 )

Most Active Art Unit
3618
Art Unit(s)
3618, 3613, 3615, 3619, 3611
Total Applications
2398
Issued Applications
1830
Pending Applications
100
Abandoned Applications
497

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17140077 [patent_doc_number] => 20210308088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => LIPID COMPOSITIONS CONTAINING BIOACTIVE FATTY ACIDS [patent_app_type] => utility [patent_app_number] => 17/233809 [patent_app_country] => US [patent_app_date] => 2021-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24518 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233809 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/233809
Lipid compositions containing bioactive fatty acids Apr 18, 2021 Issued
Array ( [id] => 19541862 [patent_doc_number] => 20240358898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => Drug Delivery System for Medical Devices [patent_app_type] => utility [patent_app_number] => 18/556142 [patent_app_country] => US [patent_app_date] => 2021-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6535 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18556142 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/556142
Drug Delivery System for Medical Devices Apr 18, 2021 Pending
Array ( [id] => 17050541 [patent_doc_number] => 20210259975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => FORMULATIONS COMPRISING HYDRALAZINE, PRAZOSIN, AND/OR NALTREXONE AND TREATMENTS USING SAME [patent_app_type] => utility [patent_app_number] => 17/234593 [patent_app_country] => US [patent_app_date] => 2021-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19120 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17234593 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/234593
Formulations comprising hydralazine, prazosin, torsemide, spironolactone, and/or naltrexone and treatments using same Apr 18, 2021 Issued
Array ( [id] => 17911217 [patent_doc_number] => 20220313612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => POLYLACTIC ACID MICROSPHERE, POLYLACTIC-CO-GLYCOLIC ACID MICROSPHERE AND METHOD OF PREPARING THE SAME [patent_app_type] => utility [patent_app_number] => 17/219179 [patent_app_country] => US [patent_app_date] => 2021-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8278 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 193 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219179 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/219179
Polylactic acid microsphere, polylactic-co-glycolic acid microsphere and method of preparing the same Mar 30, 2021 Issued
Array ( [id] => 16961444 [patent_doc_number] => 20210212943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => Dosage form comprising structured solid-solution framework of sparingly-soluble drug and method for manufacture thereof [patent_app_type] => utility [patent_app_number] => 17/207587 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38180 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17207587 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/207587
Dosage form comprising structured solid-solution framework of sparingly-soluble drug and method for manufacture thereof Mar 18, 2021 Issued
Array ( [id] => 16930863 [patent_doc_number] => 20210196752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => NON-PYROGENIC PREPARATION COMPRISING NANOPARTICLES SYNTHESIZED BY MAGNETOTACTIC BACTERIA FOR MEDICAL OR COSMETIC APPLICATIONS [patent_app_type] => utility [patent_app_number] => 17/198645 [patent_app_country] => US [patent_app_date] => 2021-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24678 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17198645 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/198645
Non-pyrogenic preparation comprising nanoparticles synthesized by magnetotactic bacteria for medical or cosmetic applications Mar 10, 2021 Issued
Array ( [id] => 16930728 [patent_doc_number] => 20210196617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => DEODORANT COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/194437 [patent_app_country] => US [patent_app_date] => 2021-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7064 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194437 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/194437
Deodorant compositions Mar 7, 2021 Issued
Array ( [id] => 18232060 [patent_doc_number] => 11596602 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-03-07 [patent_title] => Biocompatible material [patent_app_type] => utility [patent_app_number] => 17/186229 [patent_app_country] => US [patent_app_date] => 2021-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9524 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17186229 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/186229
Biocompatible material Feb 25, 2021 Issued
Array ( [id] => 17034949 [patent_doc_number] => 20210251907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => Encased Tamper Resistant Controlled Release Dosage Forms [patent_app_type] => utility [patent_app_number] => 17/185221 [patent_app_country] => US [patent_app_date] => 2021-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24227 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17185221 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/185221
Encased tamper resistant controlled release dosage forms Feb 24, 2021 Issued
Array ( [id] => 18672131 [patent_doc_number] => 20230309562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-05 [patent_title] => ANTI-MICROBIAL DISINFECTANT AND METHODS OF USE AND PRODUCTION THEREOF [patent_app_type] => utility [patent_app_number] => 17/801605 [patent_app_country] => US [patent_app_date] => 2021-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6947 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17801605 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/801605
ANTI-MICROBIAL DISINFECTANT AND METHODS OF USE AND PRODUCTION THEREOF Feb 24, 2021 Pending
Array ( [id] => 17341999 [patent_doc_number] => 20220008330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => Method and System for Manufacturing Oral Soluble Films, Compositions of Oral Soluble Films, Oral Soluble Films Made by Thereby, and Methods of Use Thereof [patent_app_type] => utility [patent_app_number] => 17/180419 [patent_app_country] => US [patent_app_date] => 2021-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33389 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17180419 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/180419
Method and System for Manufacturing Oral Soluble Films, Compositions of Oral Soluble Films, Oral Soluble Films Made by Thereby, and Methods of Use Thereof Feb 18, 2021 Abandoned
Array ( [id] => 16930970 [patent_doc_number] => 20210196859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => Cardiovascular Prostheses [patent_app_type] => utility [patent_app_number] => 17/178406 [patent_app_country] => US [patent_app_date] => 2021-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12803 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 191 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178406 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/178406
Cardiovascular Prostheses Feb 17, 2021 Abandoned
Array ( [id] => 16868408 [patent_doc_number] => 20210161875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => TOPICAL RETINOID COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/170161 [patent_app_country] => US [patent_app_date] => 2021-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20344 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17170161 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/170161
TOPICAL RETINOID COMPOSITIONS Feb 7, 2021 Abandoned
Array ( [id] => 17050756 [patent_doc_number] => 20210260190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => FRACTIONATED RADIOTHERAPY AND CHEMOTHERAPY WITH AN OXYGEN THERAPEUTIC [patent_app_type] => utility [patent_app_number] => 17/169484 [patent_app_country] => US [patent_app_date] => 2021-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6513 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169484 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/169484
Fractionated radiotherapy and chemotherapy with an oxygen therapeutic Feb 6, 2021 Issued
Array ( [id] => 16883595 [patent_doc_number] => 20210169790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-10 [patent_title] => FLEECE FOR ORAL PRODUCT WITH RELEASABLE COMPONENT [patent_app_type] => utility [patent_app_number] => 17/159701 [patent_app_country] => US [patent_app_date] => 2021-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22196 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17159701 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/159701
Fleece for oral product with releasable component Jan 26, 2021 Issued
Array ( [id] => 18496012 [patent_doc_number] => 20230218539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING THE INGREDIENT ROTIGOTINE AND AT LEAST ONE NON-AMINE-RESISTANT SILICONE ADHESIVE [patent_app_type] => utility [patent_app_number] => 17/794886 [patent_app_country] => US [patent_app_date] => 2021-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20682 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17794886 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/794886
TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING THE INGREDIENT ROTIGOTINE AND AT LEAST ONE NON-AMINE-RESISTANT SILICONE ADHESIVE Jan 21, 2021 Pending
Array ( [id] => 17272679 [patent_doc_number] => 20210378877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-09 [patent_title] => COMPOSITIONS HAVING CYLINDRICAL VOLUME, METHODS, AND APPLICATORS FOR SEALING INJURIES [patent_app_type] => utility [patent_app_number] => 17/148228 [patent_app_country] => US [patent_app_date] => 2021-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26022 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17148228 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/148228
COMPOSITIONS HAVING CYLINDRICAL VOLUME, METHODS, AND APPLICATORS FOR SEALING INJURIES Jan 12, 2021 Abandoned
Array ( [id] => 17783627 [patent_doc_number] => 11406732 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-09 [patent_title] => Tunable, controlled-release, urethane-containing elastomers and processes of forming the same [patent_app_type] => utility [patent_app_number] => 17/148130 [patent_app_country] => US [patent_app_date] => 2021-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 33 [patent_no_of_words] => 18346 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17148130 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/148130
Tunable, controlled-release, urethane-containing elastomers and processes of forming the same Jan 12, 2021 Issued
Array ( [id] => 16805927 [patent_doc_number] => 20210128480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/148320 [patent_app_country] => US [patent_app_date] => 2021-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19816 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17148320 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/148320
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof Jan 12, 2021 Issued
Array ( [id] => 19423776 [patent_doc_number] => 12083167 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-10 [patent_title] => Ovotransferrin treatment for the reproductive tract [patent_app_type] => utility [patent_app_number] => 17/146859 [patent_app_country] => US [patent_app_date] => 2021-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4911 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17146859 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/146859
Ovotransferrin treatment for the reproductive tract Jan 11, 2021 Issued
Menu